PEPG: PepGen Corp Average Forecast Price
PepGen Inc. (PEPG) relies on diversified global supply channels for biocomponents, ensuring production stability. Its client base consists of individuals with severe muscle pathologies, with therapy payments handled by health insurers. This chart of quotes against the analyst consensus is fixed at 12.71. Business revenues will grow through the implementation of gene therapy and the commercialization of drugs based on the EDO platform.
Analytical breakdowns for PepGen Inc. (PEPG)
- share price and expert price forecast:
- market capitalization information:
- shareholders' equity book value data:
- issuer credit burden and liquidity indicators:
- earnings and valuation multiples indicators:
PEPG - Company Net Income|Forward Earnings PepGen Inc.|PEPG - P/E Multiple|Projected Price to Earnings Ratio pepgen.com|PEPG - Price/Earnings to Growth Ratio|Company Value to Operating Income Before Depreciation Ratio PepGen Corp|PEPG - Operating profit EBITDA|Net earnings per share for the trailing year PepGen|PEPG - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months pepgen.com|PEPG - Earnings per share growth in current year|Projected earnings per share growth rate for next year PepGen Inc.
Summary company analytics:PEPG PepGen Inc
This indicator represents a weighted average fair value estimate of shares, aggregating the professional community's expectations regarding the business's future cash flows. By analyzing the market consensus forecast vector, an investor can assess expert confidence in the efficiency of peptide delivery to muscle tissues and the results of Duchenne muscular dystrophy tests, which determine the long-term capitalization stability of PepGen Inc. (PEPG).
Competitors of PepGen Inc.
BIIB: Forecast Levels Chart|Analyst Consensus Forecast NBIX (Neurocrine Biosciences, Inc.)|Regencell Bioscience Ltd (RGC) - Average Forecast Price|AXSM - Price Target Chart|Forecast Levels Chart ACAD|XENE: Analyst Consensus Forecast|Analyst Target Range vikingtherapeutics.com VKTX|Price Target Chart Supernus|Broker Consensus Forecast CPRX (Catalyst Pharma)|Analyst Consensus Forecast DNLI|HRMY - Average Forecast Price|Biohaven Ltd. - Consensus Target|Analyst Consensus Forecast amylyx.com AMLX|TRVI - Price Target Chart|Fair Value Consensus PRAX (Praxis Precision Medicines Inc)|Anavex Corp (AVXL) - Price Target Chart|Average Forecast Price CeriBell EEG (CBLL)|Price Target Chart Prothena Corporation PLC|Alector Therapeutics - Forecast Levels Chart|Analyst Consensus Forecast ANNX|OMER - Average Forecast Price|Price Target Chart Neurogene Corp NGNE|ACIU (AC Immune Inc) - Forecast Levels Chart|Voyager Therapeutics - Analyst Consensus Forecast|Analyst Target Range neumoratx.com (NMRA)|SCLX: Analyst Consensus Forecast|Average Forecast Price Tevogen Bio Holdings Inc. (TVGN)|Price Target Chart Alpha Cognition Inc|Broker Consensus Forecast CGTX (cogrx.com)|Consensus Target IKT (Inhibikase Therapeutics)|SAVA (cassavasciences.com) - Fair Value Consensus|Analyst Consensus Forecast ASRT (Assertio)|Analyst Median Target Coya Therapeutics Inc (COYA)|VTGN - Price Target Chart|OVID (Ovid Therapeutics Inc.) - Broker Consensus Forecast|ABOS: Analyst Consensus Forecast|Consensus Target cervomed.com|Consensus Target ATHE|Clene Nanomedicine (CLNN) - Analyst Median Target|Price Target Chart Jupiter Neurosciences Inc (JUNS)|RLMD: Forecast Levels Chart|Analyst Consensus Forecast ANVS (Annovis Bio, Inc.)|Grace Therapeutics Inc (GRCE) - Average Forecast Price|AIFF - Price Target Chart|Forecast Levels Chart KLTO|NRSN: Analyst Consensus Forecast|Analyst Target Range Reviva Pharmaceuticals, Inc. RVPH|Price Target Chart MetaVia Inc.|Broker Consensus Forecast NRXS (neuraxis.com)|Analyst Consensus Forecast HSDT|PASG - Average Forecast Price|Neuphoria Therapeutics - Consensus Target|Analyst Consensus Forecast Minerva NERV|ATHA - Price Target Chart|Fair Value Consensus ADXN (addextherapeutics.com)|alzamend.com (ALZN) - Price Target Chart|Average Forecast Price Cyclerion Therapeutics, Inc. (CYCN)|Price Target Chart Protagenic Therapeutics Inc.|Pasithea - Forecast Levels Chart|Analyst Consensus Forecast CRGT|ATXI - Average Forecast Price|Price Target Chart BrainStorm Cell Therapeutics BCLI|CARA (Cara Therapeutics Inc.) - Forecast Levels Chart|Chromocell Therapeutics Corporation - Analyst Consensus Forecast|Analyst Target Range Eliem Therapeutics (ELYM)|ITCI: Analyst Consensus Forecast|Average Forecast Price longboardpharma.com (LBPH)|Price Target Chart Marinus Pharmaceuticals, Inc.|Broker Consensus Forecast NKGN (NKGen Biotech Inc)|Consensus Target NRBO (NeuroBo)|SAGE (Sage Therapeutics Inc) - Fair Value Consensus|Analyst Consensus Forecast SNPX (Synaptogenix, Inc.)|Analyst Median Target trevena.com (TRVN)|VIGL - Price Target Chart|WENA (Anew Medical Inc.) - Broker Consensus Forecast|CERE: Analyst Consensus Forecast
